Responses
Scientific Abstracts
Late Breaking Abstracts
Late-Breaking Oral Abstracts
LB0001 Head-to-Head Comparison of TLL-018 and Tofacitinib in Patients with Active Rheumatoid Arthritis: Interim Results from a Phase IIa Study
Compose a Response to This Article
Other responses
No responses have been published for this article.